Cargando…

Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France

Detalles Bibliográficos
Autores principales: Lanéelle, D., Dadon, M., Quere, I., Zuily, S., Emmerich, J., Sevestre, M.-A., Mahé, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936/
https://www.ncbi.nlm.nih.gov/pubmed/33752851
http://dx.doi.org/10.1016/j.jdmv.2021.01.002
_version_ 1783638534972768256
author Lanéelle, D.
Dadon, M.
Quere, I.
Zuily, S.
Emmerich, J.
Sevestre, M.-A.
Mahé, G.
author_facet Lanéelle, D.
Dadon, M.
Quere, I.
Zuily, S.
Emmerich, J.
Sevestre, M.-A.
Mahé, G.
author_sort Lanéelle, D.
collection PubMed
description
format Online
Article
Text
id pubmed-7816936
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-78169362021-01-21 Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France Lanéelle, D. Dadon, M. Quere, I. Zuily, S. Emmerich, J. Sevestre, M.-A. Mahé, G. J Med Vasc Letter to the Editor Elsevier Masson SAS. 2021-04 2021-01-16 /pmc/articles/PMC7816936/ /pubmed/33752851 http://dx.doi.org/10.1016/j.jdmv.2021.01.002 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Lanéelle, D.
Dadon, M.
Quere, I.
Zuily, S.
Emmerich, J.
Sevestre, M.-A.
Mahé, G.
Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title_full Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title_fullStr Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title_full_unstemmed Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title_short Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
title_sort discontinuation of vascular therapeutics during the covid-19 pandemic first wave in france
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936/
https://www.ncbi.nlm.nih.gov/pubmed/33752851
http://dx.doi.org/10.1016/j.jdmv.2021.01.002
work_keys_str_mv AT laneelled discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT dadonm discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT querei discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT zuilys discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT emmerichj discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT sevestrema discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT maheg discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance
AT discontinuationofvasculartherapeuticsduringthecovid19pandemicfirstwaveinfrance